{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T13:40:31Z","timestamp":1777470031959,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007229","name":"Bijzonder Onderzoeksfonds UGent","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007229","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.metabol.2020.154220","type":"journal-article","created":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T11:00:12Z","timestamp":1585652412000},"page":"154220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Myeloid-specific IRE1alpha deletion reduces tumour development in a diabetic, non-alcoholic steatohepatitis-induced hepatocellular carcinoma mouse model"],"prefix":"10.1016","volume":"107","author":[{"given":"Sanne","family":"Van Campenhout","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurentijn","family":"Tilleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sander","family":"Lefere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Vandierendonck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Raevens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Verhelst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Geerts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filip","family":"Van Nieuwerburgh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Van Vlierberghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsey","family":"Devisscher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2020.154220_bb0005","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/liv.13643","article-title":"Global epidemiology of non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis: what we need in the future","volume":"38","author":"Ara\u00fajo","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.metabol.2020.154220_bb0010","doi-asserted-by":"crossref","unstructured":"Kechagias S, Nasr P, Blomdahl J, Ekstedt M. Established and emerging factors affecting the progression of nonalcoholic fatty liver disease. Metabolism 2020;0:154183. https:\/\/doi.org\/10.1016\/j.metabol.2020.154183.","DOI":"10.1016\/j.metabol.2020.154183"},{"key":"10.1016\/j.metabol.2020.154220_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17050774","article-title":"The natural course of non-alcoholic fatty liver disease","volume":"17","author":"Calzadilla Bertot","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2020.154220_bb0020","doi-asserted-by":"crossref","unstructured":"Kasmari AJ, Welch A, Liu G, Leslie D, McGarrity T, Riley T. Independent of cirrhosis, hepatocellular carcinoma risk is increased with diabetes and metabolic syndrome. Am J Med 2017;130:746.e1\u2013746.e7. https:\/\/doi.org\/10.1016\/j.amjmed.2016.12.029.","DOI":"10.1016\/j.amjmed.2016.12.029"},{"key":"10.1016\/j.metabol.2020.154220_bb0025","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/S1665-2681(19)31824-1","article-title":"Role of nonalcoholic fatty liver disease in hepatocellular carcinoma","volume":"8","author":"Ch\u00e1vez-Tapia","year":"2009","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.metabol.2020.154220_bb0030","doi-asserted-by":"crossref","unstructured":"Mantovani A, Scorletti E, Mosca A, Alisi A, Byrne CD, Targher G. Complications, morbidity and mortality of nonalcoholic fatty liver disease. Metabolism 2020;0:154170. https:\/\/doi.org\/10.1016\/j.metabol.2020.154170.","DOI":"10.1016\/j.metabol.2020.154170"},{"key":"10.1016\/j.metabol.2020.154220_bb0035","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jhep.2013.12.025","article-title":"Macrophage heterogeneity in liver injury and fibrosis","volume":"60","author":"Tacke","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2020.154220_bb0040","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1189\/jlb.5RU0116-016R","article-title":"The role of macrophages in obesity-driven chronic liver disease","volume":"99","author":"Devisscher","year":"2016","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.metabol.2020.154220_bb0045","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jhepr.2019.02.004","article-title":"Macrophages in obesity and non-alcoholic fatty liver disease: crosstalk with metabolism","volume":"1","author":"Lefere","year":"2019","journal-title":"JHEP Reports"},{"key":"10.1016\/j.metabol.2020.154220_bb0050","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cellimm.2017.10.006","article-title":"Non-alcoholic steatohepatitis induces transient changes within the liver macrophage pool","volume":"322","author":"Devisscher","year":"2017","journal-title":"Cell Immunol"},{"key":"10.1016\/j.metabol.2020.154220_bb0055","doi-asserted-by":"crossref","unstructured":"Krenkel O, Puengel T, Govaere O, Abdallah AT, Mossanen JC, Kohlhepp M, et al. Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis. Hepatology 2018;67:1270\u201383. 10.1002\/hep.29544.","DOI":"10.1002\/hep.29544"},{"key":"10.1016\/j.metabol.2020.154220_bb0060","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1055\/s-0030-1255354","article-title":"Macrophages: master regulators of inflammation and fibrosis","volume":"30","author":"Wynn","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.metabol.2020.154220_bb0065","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1172\/JCI88881","article-title":"Liver inflammation and fibrosis","volume":"127","author":"Koyama","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2020.154220_bb0070","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cell.2009.12.052","article-title":"Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression","volume":"140","author":"Park","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2020.154220_bb0075","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.canlet.2014.05.008","article-title":"Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial\u2013mesenchymal transition in hepatocellular carcinoma","volume":"352","author":"Fan","year":"2014","journal-title":"Cancer Lett"},{"key":"10.1016\/j.metabol.2020.154220_bb0080","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10555-006-9001-7","article-title":"Role of tumor-associated macrophages in tumor progression and invasion","volume":"25","author":"Mantovani","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.metabol.2020.154220_bb0085","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/ni.1857","article-title":"TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages","volume":"11","author":"Martinon","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.metabol.2020.154220_bb0090","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1038\/emboj.2013.183","article-title":"Toll-like receptor-mediated IRE1\u03b1 activation as a therapeutic target for inflammatory arthritis","volume":"32","author":"Qiu","year":"2013","journal-title":"EMBO J"},{"key":"10.1016\/j.metabol.2020.154220_bb0095","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1016\/j.celrep.2016.02.053","article-title":"Saturated fatty acids engage an IRE1\u03b1-dependent pathway to activate the NLRP3 inflammasome in myeloid cells","volume":"14","author":"Robblee","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.metabol.2020.154220_bb0100","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/ni.3709","article-title":"The metabolic ER stress sensor IRE1\u03b1 suppresses alternative activation of macrophages and impairs energy expenditure in obesity","volume":"18","author":"Shan","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.metabol.2020.154220_bb0105","doi-asserted-by":"crossref","first-page":"16657","DOI":"10.1073\/pnas.0903775106","article-title":"Function of IRE1 alpha in the placenta is essential for placental development and embryonic viability","volume":"106","author":"Iwawaki","year":"2009","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.metabol.2020.154220_bb0110","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1023\/A:1008942828960","article-title":"Conditional gene targeting in macrophages and granulocytes using LysMcre mice","volume":"8","author":"Clausen","year":"1999","journal-title":"Transgenic Res"},{"key":"10.1016\/j.metabol.2020.154220_bb0115","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00795-013-0016-1","article-title":"A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma","volume":"46","author":"Fujii","year":"2013","journal-title":"Med Mol Morphol"},{"key":"10.1016\/j.metabol.2020.154220_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(18)30878-X","article-title":"Angiopoietin-2 promotes pathological angiogenesis and is a novel therapeutic target in murine non-alcoholic fatty liver disease","author":"Lefere","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2020.154220_bb0125","doi-asserted-by":"crossref","unstructured":"EASL-EASD-EASO. EASL\u2013EASD\u2013EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. J Hepatol 2016;64:1388\u2013402. https:\/\/doi.org\/10.1016\/j.jhep.2015.11.004.","DOI":"10.1016\/j.jhep.2015.11.004"},{"key":"10.1016\/j.metabol.2020.154220_bb0130","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2020.154220_bb0135","first-page":"10","article-title":"Cutadapt removes adapter sequences from high-throughput sequencing reads","volume":"17","author":"Martin","year":"2011","journal-title":"EMBnetJournal"},{"key":"10.1016\/j.metabol.2020.154220_bb0140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.metabol.2020.154220_bb0145","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinf"},{"key":"10.1016\/j.metabol.2020.154220_bb0150","doi-asserted-by":"crossref","unstructured":"Love MI, Anders S, Huber W. Differential analysis of count data - the DESeq2 package. vol. 15. 2014. https:\/\/doi.org\/110.1186\/s13059-014-0550-8.","DOI":"10.1186\/s13059-014-0550-8"},{"key":"10.1016\/j.metabol.2020.154220_bb0155","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"10.1016\/j.metabol.2020.154220_bb0160","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1093\/bioinformatics\/bti551","article-title":"BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks","volume":"21","author":"Maere","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1016\/j.metabol.2020.154220_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013984","article-title":"Enrichment map: a network-based method for gene-set enrichment visualization and interpretation","volume":"5","author":"Merico","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2020.154220_bb0170","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jhep.2019.03.016","article-title":"Unveiling the depletion of Kupffer cells in experimental hepatocarcinogenesis through liver macrophage subtype-specific markers","volume":"71","author":"Lefere","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2020.154220_bb0175","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/hep4.1356","article-title":"Liver macrophages: old dogmas and new insights","volume":"3","author":"Guillot","year":"2019","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.metabol.2020.154220_bb0180","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cellimm.2018.01.020","article-title":"Macrophages and lipid metabolism","volume":"330","author":"Remmerie","year":"2018","journal-title":"Cell Immunol"},{"key":"10.1016\/j.metabol.2020.154220_bb0185","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1007\/s00018-018-2836-6","article-title":"Roles of heat shock factor 1 beyond the heat shock response","volume":"75","author":"Barna","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.metabol.2020.154220_bb0190","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1053\/j.gastro.2003.10.065","article-title":"Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma","volume":"126","author":"El-serag","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2020.154220_bb0195","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jhep.2017.11.029","article-title":"Type I interferon receptor signaling delays Kupffer cell replenishment during acute fulminant viral hepatitis","volume":"68","author":"Borst","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2020.154220_bb0200","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.immuni.2014.12.020","article-title":"Liver-resident macrophage necroptosis orchestrates type 1 microbicidal inflammation and type-2-mediated tissue repair during bacterial infection","volume":"42","author":"Bl\u00e9riot","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.metabol.2020.154220_bb0205","article-title":"Infiltrating monocyte-derived macrophages and resident Kupffer cells display different ontogeny and functions in acute liver injury","volume":"1400574","author":"Zigmond","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.metabol.2020.154220_bb0210","doi-asserted-by":"crossref","DOI":"10.1002\/hep.28682","article-title":"Chemokine (C-C motif) receptor 2-positive monocytes aggravate the early phase of acetaminophen-induced acute liver injury","author":"Mossanen","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2020.154220_bb0215","doi-asserted-by":"crossref","first-page":"E5096","DOI":"10.1073\/pnas.1802611115","article-title":"Distinct macrophage populations direct inflammatory versus physiological changes in adipose tissue","volume":"115","author":"Hill","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2020.154220_bb0220","series-title":"Macrophage polarization in chronic inflammatory diseases: killers or builders?","author":"Parisi","year":"2018"},{"key":"10.1016\/j.metabol.2020.154220_bb0225","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.cmet.2012.01.023","article-title":"Saturated fatty acid and TLR signaling link \u03b2 cell dysfunction and islet inflammation","volume":"15","author":"Eguchi","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2020.154220_bb0230","doi-asserted-by":"crossref","first-page":"100775","DOI":"10.1016\/j.isci.2019.100775","article-title":"Islet macrophages shift to a reparative state following pancreatic beta-cell death and are a major source of islet insulin-like growth factor-1","volume":"23","author":"Nackiewicz","year":"2020","journal-title":"IScience"},{"key":"10.1016\/j.metabol.2020.154220_bb0240","doi-asserted-by":"crossref","first-page":"E1395","DOI":"10.1073\/pnas.1621188114","article-title":"Targeting IRE1 with small molecules counteracts progression of atherosclerosis","volume":"114","author":"Tufanli","year":"2017","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.metabol.2020.154220_bb0245","doi-asserted-by":"crossref","first-page":"12743","DOI":"10.1074\/jbc.M110.199737","article-title":"Potent and selective inhibitors of the inositol-requiring enzyme 1 endoribonuclease","volume":"286","author":"Volkmann","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2020.154220_bb0250","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.metabol.2017.09.002","article-title":"Immunomodulatory liposomes targeting liver macrophages arrest progression of nonalcoholic steatohepatitis","volume":"78","author":"Maradana","year":"2018","journal-title":"Metabolism"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049520300846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049520300846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:23:37Z","timestamp":1758428617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049520300846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":49,"alternative-id":["S0026049520300846"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2020.154220","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myeloid-specific IRE1alpha deletion reduces tumour development in a diabetic, non-alcoholic steatohepatitis-induced hepatocellular carcinoma mouse model","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2020.154220","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154220"}}